ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
202.76
+4.19 (2.11%)
Jul 16, 2026, 4:00 PM EDT - Market closed
ResMed Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, ResMed stock has a consensus rating of "Buy" and an average price target of $252.2. The average 1-year stock price forecast is 24.38% higher than the current stock price, while the lowest is $180 (-11.23%) and the highest is $325 (+60.29%).
Price Target: $252.2 (+24.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 8 | 8 | 6 |
| Buy | 3 | 3 | 3 | 2 | 1 | 2 |
| Hold | 7 | 7 | 7 | 7 | 8 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 19 | 19 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $235 → $220 | Buy | Maintains | $235 → $220 | +8.50% | Jul 15, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $230 | Hold | Maintains | $230 | +13.43% | Jul 14, 2026 |
| Jefferies | Jefferies | Hold Maintains $225 | Hold | Maintains | $225 | +10.97% | Jul 10, 2026 |
| Citi | Citi | Hold Downgrades $270 → $235 | Hold | Downgrades | $270 → $235 | +15.90% | Jul 10, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 8, 2026 |
Financial Forecast
Revenue This Year
5.65B
from 5.15B
Increased by 9.79%
Revenue Next Year
6.10B
from 5.65B
Increased by 7.96%
EPS This Year
11.11
from 9.55
Increased by 16.31%
EPS Next Year
12.07
from 11.11
Increased by 8.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.